ArticleJournal of the National Cancer Institute2014

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

Matthew P Goetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.